139 related articles for article (PubMed ID: 31912556)
1. Radiosynthesis of the
Teyssier VR; Simard JM; Dornan MH; Tournoux F; DaSilva JN
J Labelled Comp Radiopharm; 2020 Feb; 63(2):65-71. PubMed ID: 31912556
[TBL] [Abstract][Full Text] [Related]
2. Novel O-[
Teyssier VR; Tournoux F; Simard JM; Gaudette F; Boudjemeline M; Petrenyov DR; DaSilva JN
Nucl Med Biol; 2021; 102-103():34-44. PubMed ID: 34601168
[TBL] [Abstract][Full Text] [Related]
3. Structure of neprilysin in complex with the active metabolite of sacubitril.
Schiering N; D'Arcy A; Villard F; Ramage P; Logel C; Cumin F; Ksander GM; Wiesmann C; Karki RG; Mogi M
Sci Rep; 2016 Jun; 6():27909. PubMed ID: 27302413
[TBL] [Abstract][Full Text] [Related]
4. Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
Hubers SA; Brown NJ
Circulation; 2016 Mar; 133(11):1115-24. PubMed ID: 26976916
[TBL] [Abstract][Full Text] [Related]
5. Disposition and metabolism of [(14)C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects.
Flarakos J; Du Y; Bedman T; Al-Share Q; Jordaan P; Chandra P; Albrecht D; Wang L; Gu H; Einolf HJ; Huskey SE; Mangold JB
Xenobiotica; 2016 Nov; 46(11):986-1000. PubMed ID: 26931777
[TBL] [Abstract][Full Text] [Related]
6. Radiosynthesis of a carbon-11 labeled PDE5 inhibitor [
Xu Z; Jia L; Liu W; Li W; Song Y; Zheng QH
Appl Radiat Isot; 2020 Aug; 162():109190. PubMed ID: 32501230
[TBL] [Abstract][Full Text] [Related]
7. Radiosynthesis of the diastereomerically pure (E)-[
Bdair H; Tsai IH; Smart K; Benkelfat C; Leyton M; Kostikov A
J Labelled Comp Radiopharm; 2019 Oct; 62(12):860-864. PubMed ID: 31418468
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of a Precursor to Sacubitril Using Enabling Technologies.
Lau SH; Bourne SL; Martin B; Schenkel B; Penn G; Ley SV
Org Lett; 2015 Nov; 17(21):5436-9. PubMed ID: 26509957
[TBL] [Abstract][Full Text] [Related]
9. Neprilysin inhibition with sacubitril/valsartan in the treatment of heart failure: mortality bang for your buck.
Ansara AJ; Kolanczyk DM; Koehler JM
J Clin Pharm Ther; 2016 Apr; 41(2):119-27. PubMed ID: 26992459
[TBL] [Abstract][Full Text] [Related]
10. Long-term neprilysin inhibition - implications for ARNIs.
Campbell DJ
Nat Rev Cardiol; 2017 Mar; 14(3):171-186. PubMed ID: 27974807
[TBL] [Abstract][Full Text] [Related]
11. Spotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to date.
Vilela-Martin JF
Drug Des Devel Ther; 2016; 10():1627-39. PubMed ID: 27274196
[TBL] [Abstract][Full Text] [Related]
12. The angiotensin II type 1 receptor-neprilysin inhibitor LCZ696 blocked aldosterone synthesis in a human adrenocortical cell line.
Miura SI; Suematsu Y; Matsuo Y; Tomita S; Nakayama A; Goto M; Arimura T; Kuwano T; Yahiro E; Saku K
Hypertens Res; 2016 Nov; 39(11):758-763. PubMed ID: 27334058
[TBL] [Abstract][Full Text] [Related]
13. Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.
Nougué H; Pezel T; Picard F; Sadoune M; Arrigo M; Beauvais F; Launay JM; Cohen-Solal A; Vodovar N; Logeart D
Eur J Heart Fail; 2019 May; 21(5):598-605. PubMed ID: 30520545
[TBL] [Abstract][Full Text] [Related]
14. Radiosynthesis of a carbon-11 labeled tetrahydrobenzisoxazole derivative as a new PET probe for γ-secretase imaging in Alzheimer's disease.
Xu Z; Miao C; Dong F; Jia L; Li W; Wang M; Liu W; Zheng QH
Appl Radiat Isot; 2020 Jan; 155():108915. PubMed ID: 31590101
[TBL] [Abstract][Full Text] [Related]
15. Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology.
Hashimoto H; Kawamura K; Igarashi N; Takei M; Fujishiro T; Aihara Y; Shiomi S; Muto M; Ito T; Furutsuka K; Yamasaki T; Yui J; Xie L; Ono M; Hatori A; Nemoto K; Suhara T; Higuchi M; Zhang MR
J Nucl Med; 2014 Sep; 55(9):1532-8. PubMed ID: 24963128
[TBL] [Abstract][Full Text] [Related]
16. Automated GMP-production of α-[
Nordeman P; Yngve U; Wilking H; Gustavsson SÅ; Eriksson J; Antoni G
J Labelled Comp Radiopharm; 2018 Dec; 61(14):1106-1109. PubMed ID: 29902836
[TBL] [Abstract][Full Text] [Related]
17. Dual Angiotensin Receptor and Neprilysin Inhibition with Sacubitril/Valsartan in Chronic Systolic Heart Failure: Understanding the New PARADIGM.
Lillyblad MP
Ann Pharmacother; 2015 Nov; 49(11):1237-51. PubMed ID: 26175499
[TBL] [Abstract][Full Text] [Related]
18. The automated radiosynthesis and purification of the opioid receptor antagonist, [6-O-methyl-11C]diprenorphine on the GE TRACERlab FXFE radiochemistry module.
Fairclough M; Prenant C; Brown G; McMahon A; Lowe J; Jones A
J Labelled Comp Radiopharm; 2014 May; 57(5):388-96. PubMed ID: 24692062
[TBL] [Abstract][Full Text] [Related]
19. Sacubitril/Valsartan (LCZ696) in Heart Failure.
Khder Y; Shi V; McMurray JJV; Lefkowitz MP
Handb Exp Pharmacol; 2017; 243():133-165. PubMed ID: 28004291
[TBL] [Abstract][Full Text] [Related]
20. Radiosynthesis of carbon-11 labeled PDE5 inhibitors as new potential PET radiotracers for imaging of Alzheimer's disease.
Dong F; Du J; Miao C; Jia L; Li W; Wang M; Zheng QH; Xu Z
Appl Radiat Isot; 2019 Dec; 154():108873. PubMed ID: 31470193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
